What kind of late effects of antineoplastic treatment  can we meet in children treated for neoplastic disease?

Joanna Stefanowicz; Teresa Stachowicz-Stencel; Danuta Sierota; Elżbieta Adamkiewicz-Drożyńska; Ewa Bień; Katarzyna Połczyńska; Anna Szołkiewicz; Anna Synakiewicz; Dorota Birkholz; Anna Balcerska

eISSN: 1897-4309
ISSN: 1428-2526

Contemporary Oncology/Współczesna Onkologia

Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

4/2009
vol. 13

Send email

Copy url:

abstract:

Original paper

What kind of late effects of antineoplastic treatment can we meet in children treated for neoplastic disease?

Joanna Stefanowicz

,

Teresa Stachowicz-Stencel

,

Danuta Sierota

,

Elżbieta Adamkiewicz-Drożyńska

,

Ewa Bień

,

Katarzyna Połczyńska

,

Anna Szołkiewicz

,

Anna Synakiewicz

,

Dorota Birkholz

,

Anna Balcerska

Współczesna Onkologia (2009) vol. 13; 4 (206-211)

Online publish date: 2009/09/15

View full text Get citation

The five-year survival rate for children suffering from neoplastic disease is currently 80-85%. Thus, the number of children cured of neoplasms is still increasing.
Aim of the study: Analysis of prevalence of long-term consequences of disease and antineoplastic treatment.
Material and methods: The study group consisted of 10 children who were treated for neuroblastoma (NBL) and soft tissue sarcomas (STS) at the Department of Paediatrics, Haematology, Oncology and Endocrinology, Medical University of Gdansk, between 1992 and 2004. All patients had complete physical and laryngological examination. The basic biochemical tests in blood and urea were performed and the level of sex hormones determined for every patient. ECG, echocardiography, ultrasonography of the abdomen, audiogram and three times repeated blood pressure taking was made in order to exclude arterial hypertension.
Results: The following abnormalities were observed: neurological (flaccid paresis of lower limbs) (2 patients), nephrological (state after urinary bladder resection and operation of ureter implantation into ileal conduit and ureterocutaneostomy) (1), ophthalmic (post enucleation state), endocrine (somatotropic hypopituitarism) (1), laryngological (sensorineural hypoacusis at high frequencies) (2), chronic hepatitis type C (1), type B (2), vascular: stenosis of inferior vein (complication after nephrectomy). Moreover, haemodynamic insignificant cardiac defects in the form of mitral insufficiency (2) and tricuspid insufficiency (2) were diagnosed.
Conclusions: Patients who completed the antineoplastic treatment need routine control tests and regular secondary medical care to ensure early detection and monitor long-term consequences of both disease and treatment.

keywords:

What kind of late effects of antineoplastic treatment can we meet in children treated for neoplastic disease?

Joanna Stefanowicz , Teresa Stachowicz-Stencel , Danuta Sierota , Elżbieta Adamkiewicz-Drożyńska , Ewa Bień , Katarzyna Połczyńska , Anna Szołkiewicz , Anna Synakiewicz , Dorota Birkholz , Anna Balcerska

malignant neoplasms, late effects, treatment, children

Joanna Stefanowicz

,

Teresa Stachowicz-Stencel

,

Danuta Sierota

,

Elżbieta Adamkiewicz-Drożyńska

,

Ewa Bień

,

Katarzyna Połczyńska

,

Anna Szołkiewicz

,

Anna Synakiewicz

,

Dorota Birkholz

,

Anna Balcerska